Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia

R Thadhani, T Kisner, H Hagmann, V Bossung… - Circulation, 2011 - Am Heart Assoc
Background—Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

[PDF][PDF] Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

R Thadhani, T Kisner, H Hagmann, V Bossung… - 2011 - uniklinikum-leipzig.de
Background—Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

[PDF][PDF] Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

R Thadhani, T Kisner, H Hagmann, V Bossung… - 2011 - scholar.archive.org
Background—Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

R Thadhani, T Kisner, H Hagmann, V Bossung… - Circulation, 2011 - cir.nii.ac.jp
< jats: sec>< jats: title> Background—</jats: title>< jats: p> Targeted therapies to stabilize the
clinical manifestations and prolong pregnancy in preeclampsia do not exist. Soluble fms-like …

Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia

R Thadhani, T Kisner, H Hagmann, V Bossung… - …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

R Thadhani, T Kisner, H Hagmann, V Bossung… - 2011 - Am Heart Assoc
Background—Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

[PDF][PDF] Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

R Thadhani, T Kisner, H Hagmann, V Bossung… - 2011 - academia.edu
Background—Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

[PDF][PDF] Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

R Thadhani, T Kisner, H Hagmann, V Bossung… - 2011 - researchgate.net
Background—Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia.

R Thadhani, T Kisner, H Hagmann, V Bossung… - Circulation, 2011 - europepmc.org
Background Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

[引用][C] Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia

R THADHANI, T KISNER, L HEMPHILL… - … (New York, NY), 2011 - pascal-francis.inist.fr
Pilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …